课题基金 / 基金详情

RESIDUAL LEUKEMIA LEVELS DURING SECOND REMISSION IN ALL

RESIDUAL LEUKEMIA LEVELS DURING SECOND REMISSION IN ALL
第二次缓解期间所有患者的残余白血病水平
批准号：
2443175
负责人：
THEODORE F ZIPF
金额：
$14.68万
依托单位：
UNIVERSITY OF TX MD ANDERSON CAN CTR
依托单位国家：
美国
项目类别：
财政年份：
1996
资助国家：
美国
项目状态：
已结题
起止时间：
1996-07-01 至 1999-06-30
来源：
https://reporter.nih.gov/project-details/2443175
关键词：
RNA acute lymphocytic leukemia bioassay bone marrow bone marrow transplantation child (0-11) clinical research cytogenetics gene rearrangement graft versus host disease human genetic material tag human subject human therapy evaluation longitudinal human study neoplasm /cancer chemotherapy neoplasm /cancer relapse /recurrence neoplasm /cancer remission /regression neoplasm /cancer transplantation neoplastic cell nucleic acid sequence pediatric neoplasm /cancer pediatric pharmacology polymerase chain reaction statistics /biometry tissue /cell culture

项目成果

THEODORE F ZIPF的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RESIDUAL LEUKEMIA LEVELS DURING SECOND REMISSION IN ALL
RESIDUAL LEUKEMIA LEVELS DURING SECOND REMISSION IN ALL
海外基金